ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Community Assn. Meeting Includes Provocative Workshops

January 31, 1975

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

In Brief: Orvile Kelley, Make Today Count Founder, Dies; Elli Kohen Honored By Pap Institute

July 4, 1980

Cancer Survivorship: NCI, Komen, OWH Fund Research Grants

December 5, 1997

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012